John Helou

Biography

Mr. John Helou has been the President of Pfizer Canada, Inc. since January 31, 2012. Mr. Helou serves as General Manager of Specialty Care at Pfizer Canada Inc. Mr. Helou serves as a Director of BIOTECanada. Mr. Helou is a veteran of more than 25 years in the pharmaceutical industry and head of the Pfizer Specialty Care Business Unit (SCBU) for Canada. He began his career as a Chemical Engineer with DuPont Canada in 1980, moving five years later to the DuPont's pharmaceutical business where he took positions of increasing responsibility in sales, marketing, strategic planning and business development in Canada, the U.S. and at the global level. In 1997, Mr. Helou set up and became General Manager of Agouron Canada, the Canadian operations of a start-up biotech company specializing in HIV/AIDS and oncology treatments. Agouron was subsequently acquired by Pfizer and the business operations transferred in 2003, at which time he was appointed as Pfizer Canada's Director of Sales for its Specialty Business. In 2006, he served as the Vice-President of Public Affairs and Stakeholder Relations, before being named head of the SCBU when it was formed in 2009. Mr. Helou holds a Degree in Chemical Engineering from the University of Toronto.

Research Interest

Sales, Marketing, Strategic planning and Business development